IIFL Securities Stock Market Watch Today: Buy Alembic Pharma - July 22

IIFL Securities has issued a buy call for Alembic Pharma, setting a target price of Rs 1200. As of July 22nd, the current market price of Alembic Pharma is Rs 1157.55. This represents a potential upside of approximately 3.6% for investors who follow this recommendation.

About Alembic Pharma:

Alembic Pharmaceuticals Ltd. is a multinational pharmaceutical company headquartered in Vadodara, India. Listed on the National Stock Exchange (NSE) of India, it manufactures and markets generic, branded generic, and over-the-counter (OTC) products. Alembic has a strong presence in India and exports to over 90 countries worldwide. The company's key therapeutic areas include anti-infectives, gastrointestinal, cardiovascular, central nervous system, and diabetes. Alembic has state-of-the-art manufacturing facilities in India, the United States, and Australia and employs over 10,000 people globally.

52 Week Price Trend:

Alembic Pharmaceuticals (APLLTD), currently trading at Rs 1157.55, has exhibited significant growth compared to its 52-week high of Rs 1094. This represents an increase of approximately 5.8%. However, it is worth noting that the stock has experienced a notable rise since its 52-week low of Rs 462.3, indicating a substantial appreciation of over 150%. The company's strong financial performance and consistent growth in key markets have contributed to this positive trend.

Stratzy's MOST Analysis:

APLLTD has been rated BB- by Stratzy's MOST framework, which evaluates Management, Outlook, Safety, and Trend. This indicates that APLLTD has medium fundamental risks and falls into the "BB" category. Stratzy's scoring system takes into account factors such as the company's financial performance, management effectiveness, industry outlook, and overall risk profile. The BB- rating suggests that while APLLTD has some positive aspects, there may be certain risks investors should consider before investing in the stock.

Company's Fundamentals:

Alembic Pharma (NSE: APLLTD) is currently trading at a Stock PE of 34.88, indicating that investors are willing to pay Rs. 34.88 for every rupee of earnings. The PB Ratio of 4.61 suggests that the market value of Alembic Pharma's assets is 4.61 times its book value. Finally, the Dividend Yield of 0.76% implies that investors can expect to receive Rs. 0.76 in dividends for every Rs. 100 invested in the company. These metrics provide insights into Alembic Pharma's valuation, profitability, and income distribution, helping investors make informed investment decisions.

Fundamental and Technical information provided in this blog were last updated on 20 Jul, 2024

Optimize Your Trading with Algorithms: Enhance your trading strategies with our Algo Trading service, designed to provide optimal trading algorithms. Check it out and download our app for seamless access!

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.